Shares of Aspen Pharmacare (OTCMKTS:APNHY – Get Free Report) saw unusually-high trading volume on Monday . Approximately 1,461 shares changed hands during trading, an increase of 72% from the previous session’s volume of 850 shares.The stock last traded at $7.19 and had previously closed at $6.83.
Aspen Pharmacare Price Performance
The business has a 50-day moving average of $5.84 and a 200 day moving average of $6.00. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.18.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited is a multinational pharmaceutical company headquartered in Durban, South Africa. Founded in 1997 by Stephen Saad and Gus Attridge, Aspen has grown from a regional generic drug producer into a global specialist in branded and generic medicines. The company is publicly traded on the Johannesburg Stock Exchange and its American depositary receipts trade over?the?counter under the symbol APNHY.
Aspen’s core business encompasses the development, manufacture and distribution of a broad portfolio of injectable and oral pharmaceutical products.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- This AI Opportunity Was Built to Evolve With Demand
- Punch these codes into your ordinary brokerage account
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Zacks Puts $25.50 target on BSEM!
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.
